Background: Bidirectional Glenn shunt (BDG) failure carries high morbidity and mortality but the clinical factors associated with failure and the optimal management strategy are understudied. Methods: A total of 217 patients undergoing BDG at our institution between 1989 and 2020 were retrospectively reviewed and categorized as success or failure. Failure was defined as the need for reoperation (BDG takedown, reoperation for correction of cardiac defect, and/or transplantation) at any time postoperatively; operative mortality (death attributable to BDG malfunction occurring during the index hospitalization for BDG or within 30 days of discharge); or late mortality (death directly attributable to BDG malfunction occurring prior to Fontan or next-stage palliation). Univariate and binary logistic regression analyses were performed. Results: BDG failure occurred in 14 (6.5%) patients. Univariate predictors were: hypoplastic left heart syndrome (P = .037), right ventricular (RV) dominance (P = .010), greater pre-BDG pulmonary vascular resistance (PVR) (P = .012), concomitant atrioventricular valve repair (P = .020), prolonged pleural drainage (P = .001), intensive care unit (P<.001) and hospital (P = .002) stays, and extracorporeal membrane oxygenation (ECMO) requirement (P<.001). Multivariate predictors were: RV dominance (P = .002), greater PVR (P = .041), ICU (P<.001) and hospital (P = .020) stays, and need for ECMO (P<.001). As many as 10 of 14 (71%) patients with BDG failure died. Reoperation was performed for 10 patients with BDG failure. Five reoperation patients survived until discharge, with four patients alive at last follow-up (mean 7.9 years). Survivors underwent reoperation earlier than nonsurvivors (36 vs. 94 days). Conclusions: BDG failure carries high mortality, but preoperative predictors and postoperative indicators of failure exist. Early BDG takedown and insertion of aorta-pulmonary shunt may allow survival.
CarlonCAMondiniPGDe MarchiR. Surgical treatment of some cardiovascular diseases. J Int Coll Surg. 1951;16(1):1-11.
2.
MeshalkinEN. Anastomosis of the upper vena cava with the pulmonary artery in patients with congenital heart disease with blood flow insufficiency in the lesser circulation. Eksp Khirurgiia. 1956;1(6):3-12.
3.
GlennWW. Circulatory bypass of the right side of the heart. IV. Shunt between superior vena cava and distal right pulmonary artery; report of clinical application. N Engl J Med. 1958;259(3):117-120.
4.
AzzolinaGEufrateSPensaP. Tricuspid atresia: experience in surgical management with a modified cavopulmonary anastomosis. Thorax. 1972;27(1):111-115.
5.
JacobsJPMayerJEJrMavroudisC, et al. The Society of Thoracic Surgeons congenital heart surgery database: 2016 update on outcomes and quality. Ann Thorac Surg. 2016;101(3):850-862.
6.
MenonSCMcCandlessRTMackGK, et al.Clinical outcomes and resource use for infants with hypoplastic left heart syndrome during bidirectional Glenn: summary from the Joint Council for Congenital Heart Disease National Pediatric Cardiology Quality Improvement Collaborative registry. Pediatr Cardiol. 2013;34(1):143-148.
7.
HerrmannJLBrownJW. The superior cavopulmonary connection: history and current perspectives. World J Pediatr Congenit Heart Surg. 2019;10(2):216-222.
8.
MezaJMHickeyEMcCrindleB, et al.The optimal timing of stage-2-palliation after the Norwood operation. Ann Thorac Surg. 2018;105(1):193-199.
9.
MezaJMHickeyEJBlackstoneEH, et al.The optimal timing of stage 2 palliation for hypoplastic left heart syndrome: an analysis of the pediatric heart network single ventricle reconstruction trial public data set. Circulation. 2017;136(18):1737-1748.
10.
AlsoufiBManlhiotCAwanA, et al.Current outcomes of the Glenn bidirectional cavopulmonary connection for single ventricle palliation. Eur J Cardiothorac Surg. 2012;42(1):42-48. Discussion 8–9.
11.
ScheurerMAHillEGVasukiN, et al.Survival after bidirectional cavopulmonary anastomosis: analysis of preoperative risk factors. J Thorac Cardiovasc Surg. 2007;134(1):82-89. 9 e1–2.
12.
LeeTMAiyagariRHirschJCOhyeRGBoveELDevaneyEJ. Risk factor analysis for second-stage palliation of single ventricle anatomy. Ann Thorac Surg. 2012;93(2):614-618. Discussion 9.
13.
BarronDJHaqIUCruceanA, et al.The importance of age and weight on cavopulmonary shunt (stage II) outcomes after the Norwood procedure: planned versus unplanned surgery. J Thorac Cardiovasc Surg. 2017;154(1):228-238.
14.
Baker-SmithCMGoldbergSWRosenthalGL. Predictors of prolonged hospital length of stay following stage II palliation of hypoplastic left heart syndrome (and variants): analysis of the national pediatric cardiology quality improvement collaborative (NPC-QIC) database. Pediatr Cardiol. 2015;36(8):1630-1641.
15.
ClevelandJDTranSTakaoCWellsWJStarnesVAKumarSR. Need for pulmonary arterioplasty during Glenn independently predicts inferior surgical outcome. Ann Thorac Surg. 2018;106(1):156-164.
16.
HuntMLIttenbachRFKaplinskiM, et al.Outcomes for the superior cavopulmonary connection in children with hypoplastic left heart syndrome: a 30-year experience. Eur J Cardiothorac Surg. 2020;58(4):809-816.
17.
HoeperMMBogaardHJCondliffeR, et al.Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 Suppl):D42-D50.
18.
ZoghbiWAEnriquez-SaranoMFosterE, et al.Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr. 2003;16(7):777-802.
19.
NorwoodWI Jr.JacobsMLMurphyJD. Fontan procedure for hypoplastic left heart syndrome. Ann Thorac Surg. 1992;54(6):1025-1029; discussion 9–30.
20.
JacobsMLRychikJRomeJJ, et al.Early reduction of the volume work of the single ventricle: the hemi-Fontan operation. Ann Thorac Surg. 1996;62(2):456-461. discussion 61–2.
